Biora Therapeutics, Inc.
BIORDelisted Jun 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580063
Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Biora Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 36 | 57 | +21 |
| Shares | 47.9M | 48.5M | +529.6K (+1.1%) |
| Value | $72.8M | $101.3M | +$28.4M (+39.0%) |
New holders (32)
Institutions that held Biora Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (11)
Institutions that held Biora Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Renaissance Technologies LLC | 814,700 | $1.24M |
| Birchview Capital, LP | 270,000 | $410.0K |
| Susquehanna Fundamental Investments, LLC | 98,400 | $150.0K |
| Group One Trading, L.P. | 84,909 | $129.0K |
| Sassicaia Capital Advisers LLC | 67,000 | $102.0K |
| Raymond James & Associates | 22,000 | $33.0K |
| Eagle Asset Management Inc | 15,935 | $24.0K |
| UBS Group AG | 15,462 | $24.0K |
| Manufacturers Life Insurance Company, The | 13,396 | $20.0K |
| Schonfeld Strategic Advisors LLC | 12,900 | $20.0K |
| Cetera Advisors LLC | 12,000 | $18.0K |